Skip to main content
. 2009 Sep 24;101(20):1412–1422. doi: 10.1093/jnci/djp319

Table 2.

Unit costs per person per year in 2007 US dollars for colorectal cancer treatment, by stage, phase of care, and treatment scenario, used as inputs for the MISCAN-Colon model*

Terminal
Scenario Stage Initial Continuous Death from CRC Death from other cause
Past I 24 472 2033 36 495 7361
II 31 878 2033 36 534 4849
III 35 742 3727 38 485 7515
IV 34 132 8809 37 288 12 906
Present I 28 668 2395 51 935 12 703
II 39 700 2237 51 712 11 035
III 48 951 3249 54 776 14 708
IV 64 801 10 419 73 522 39 679
Near future I 28 668 2395 111 935 12 703
II 39 700 2237 111 712 11 035
III 79 801 3249 114 776 14 708
IV 79 801 10 419 133 522 39 679

Note: CRC, colorectal cancer

*

Costs for care were divided into three clinically relevant phases of care—initial, continuing, and terminal care. The initial phase was defined as the first 12 months following diagnosis, the terminal phase was defined as the final 12 months of life, and the continuing phase was defined as the period between the initial and terminal phases of care. The terminal care phase for colorectal cancer patients was further subdivided into terminal care preceding colorectal cancer death and terminal care preceding death from other causes. For patients surviving less than 24 months after diagnosis, the final 12 months of observation and costs of care were then allocated to the terminal phase. The remaining time was allocated to the initial phase, and no time was allocated to the continuing phase.